Blockade of transforming growth factor-beta signaling does not abrogate antiestrogen-induced growth inhibition of human breast carcinoma cells.
作者:
主题词
乳腺肿瘤(Breast Neoplasms);周期素依赖激酶抑制剂p21(Cyclin-Dependent Kinase Inhibitor p21);细胞周期蛋白类(Cyclins);酶抑制剂(Enzyme Inhibitors);雌激素拮抗剂(Estrogen Antagonists);女(雌)性(Female);人类(Humans);受体, 转化生长因子β(Receptors, Transforming Growth Factor beta);他莫昔芬(Tamoxifen);转化生长因子β(Transforming Growth Factor beta);肿瘤细胞, 培养的(Tumor Cells, Cultured);增量调节(Up-Regulation)
DOI
10.1074/jbc.272.13.8296
PMID
9079651
发布时间
2021-12-03
- 浏览12
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文